Catalyst Wire Dossier Catalyst Wire Dossier

CLOBETASOL PROPIONATE (EMOLLIENT)

clobetasol propionate · E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CLOBETASOL PROPIONATE (EMOLLIENT), covering 2007-03-16 to 2018-05-21. Get the full timeline:

Most recent: FDA Approved: CLOBETASOL PROPIONATE (EMOLLIENT) — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)

See pricing